-
Posted by
Two Blokes Jun 4 -
Filed in
Stock
-
6 views
On Tuesday, Zydus Lifesciences Ltd. announced its entry into the global biologics contract development and manufacturing organization (CDMO) business through its plan to acquire Agenus Inc.'s AGEN U.S.-based biologics CMC facilities.
